Atlas Trials

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Clinical trial NCT01467323 · COMPLETED

Trial details

NCT number
NCT01467323
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Start date
1998-04-01
Primary completion
1998-09-01
Enrollment
303

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.